What are the management options for Atrioventricular Nodal Reentrant Tachycardia (AVNRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

AVNRT Management

For acute AVNRT termination in hemodynamically stable patients, start with vagal maneuvers (particularly the modified Valsalva technique), followed by adenosine 6 mg IV rapid push if vagal maneuvers fail, then IV calcium channel blockers (diltiazem or verapamil) or beta-blockers as third-line, with catheter ablation of the slow pathway as the definitive long-term solution. 1, 2, 3

Acute Management Algorithm

First-Line: Vagal Maneuvers

  • Perform vagal maneuvers with the patient in the supine position as the initial intervention 4, 1, 2
  • The modified Valsalva maneuver is 2.8-3.8 times more effective than the standard technique 2, 3
  • Have the patient bear down against a closed glottis for 10-30 seconds, generating intrathoracic pressure of at least 30-40 mmHg 4, 2
  • Carotid sinus massage is an alternative but less effective option; apply steady pressure over the carotid sinus for 5-10 seconds after confirming absence of bruits by auscultation 4, 2
  • Overall success rate of vagal maneuvers is approximately 27.7%, with Valsalva being more successful than carotid massage 4

Second-Line: Adenosine

  • Administer adenosine 6 mg as a rapid IV push through a large vein, followed immediately by saline flush 2, 3
  • Adenosine terminates AVNRT in approximately 90-95% of patients 4, 3
  • Have cardioversion equipment ready during administration due to potential for transient arrhythmias 3, 5
  • Adenosine works by inhibiting calcium influx through slow channels in the AV node, interrupting the reentrant circuit 4, 5

Critical Safety Point: Ensure the rhythm is truly AVNRT before administering adenosine or calcium channel blockers, as these agents can be dangerous in ventricular tachycardia or pre-excited atrial fibrillation 1, 2

Third-Line: IV Calcium Channel Blockers or Beta-Blockers

  • IV diltiazem or verapamil achieve 80-98% success rates in resistant cases 2, 3
  • Verapamil works by inhibiting calcium influx through slow channels, slowing AV conduction and prolonging the effective refractory period within the AV node 6
  • Administer verapamil 5-10 mg IV, which produces peak therapeutic effects within 3-5 minutes 6
  • Beta-blockers (esmolol, metoprolol) are less effective than calcium channel blockers but have an excellent safety profile 3
  • Avoid calcium channel blockers in patients with severe conduction abnormalities, sinus node dysfunction, or acute decompensated heart failure 4, 6

Hemodynamically Unstable Patients

  • Perform immediate synchronized cardioversion using 50-100J initial energy 1, 2

Long-Term Management Options

Definitive Therapy: Catheter Ablation

  • Catheter ablation of the slow pathway is the first-line definitive treatment with a success rate of 94.3-98.5% 1, 3
  • Slow pathway ablation is preferred over fast pathway ablation due to lower risk of AV block 3
  • Ablation is potentially curative and eliminates the need for chronic pharmacological therapy 3
  • Radiofrequency energy is applied at sites showing discrete slow potentials in the perinodal region 7

Pharmacological Prophylaxis (For Patients Not Pursuing Ablation)

  • Oral verapamil or diltiazem are first-line pharmacological options 1, 3
  • Oral beta-blockers are effective alternatives 1
  • Other options include digitalis and class Ia, Ic, and III antiarrhythmic agents 8
  • Avoid beta-blockers in patients with severe conduction abnormalities or sinus node dysfunction 1

Important Clinical Considerations

Transition to Maintenance Therapy

  • Transition to oral antiarrhythmic agents is generally safe within 3 hours after acute treatment 9
  • Options include oral digoxin, calcium channel blockers, beta-blockers, or class I antiarrhythmics 9

Common Pitfalls to Avoid

  • Never administer verapamil or diltiazem to patients with pre-excited atrial fibrillation—these patients require immediate cardioversion 2
  • Do not use calcium channel blockers in patients with severe heart failure (pulmonary wedge pressure >20 mmHg, ejection fraction <30%) as acute worsening may occur 6
  • Avoid applying pressure to the eyeball as a vagal maneuver—this practice is potentially dangerous and has been abandoned 4

Post-Conversion Management

  • Atrial or ventricular premature complexes may occur immediately after conversion 2
  • An antiarrhythmic drug may be required to prevent acute reinitiation 2

References

Guideline

Atrioventricular Nodal Reentrant Tachycardia (AVNRT) Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Modified Valsalva Maneuver for Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

AVNRT Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.